employer coverage glp-1 news october 2025 Drugs: What Employers Need to Know Employer FAQs on the Rise
Description
Over ...
Tirzepatide (Zepbound/Mounjaro): A dual GLP-1/GIP receptor agonist undergoing evaluation for MASH after demonstrating significant liver fat reduction in studies.Retatrutide: A "triple agonist" targeting GLP-1, GIP, and glucagon (GCGR) receptors, which has shown "unprecedented" efficacy in weight loss and is being evaluated for metabolic diseases including MASH
For best results, combine with a balanced diet, regular physical activity, and mindful lifestyle habits
One of the best fat burner capsules for weight management.
